THE EUROPEAN MEDICINES AGENCY - NL 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 2.281.840 78.756 1
2020 0 4.550.000 47.000 1
2019 0 17.285.991 92.500 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE INC2
BAYER2
BRISTOLMYERS SQUIBB COMPANY CORP2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
KATHOLIEKE UNIVERSITEIT LEUVEN2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NOVARTIS PHARMA2
PFIZER LIMITED2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
SANOFIAVENTIS2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ADELPHI VALUES1
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
AGENZIA REGIONALE DI SANITA1
AGES OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT1
ASTRAZENECA1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIONOTUS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
COVANCE LABORATORIES1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
ECT OEKOTOXIKOLOGIE1
EIDGENOESSISCHE ANSTALT FUER WASSERVERSORGUNG ABWASSERREINIGUNG UND GEWAESSERSCHUTZ1
ELEVATE BV1
ELI LILLY AND COMPANY1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
ESD EVALUATION SOFTWARE DEVELOPMENT1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY1
F HOFFMANNLA ROCHE1
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
FUNDACION PUBLICA MIGUEL SERVET1
GOETEBORGS UNIVERSITET1
HEALTH PRODUCTS REGULATORY AUTHORITY1
INFARMED AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
JANSSEN PHARMACEUTICA NV1
JOHNS HOPKINS UNIVERSITY1
KAROLINSKA INSTITUTE1
KLINICKI BOLNICKI CENTAR RIJEKA1
LAAKEALAN TURVALLISUUSJA KEHITTAMISKESKUS1
LAKEMEDELSVERKET1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LEUPHANA UNIVERSITAT LUNEBURG1
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK SHARP & DOHME CORP1
MODUS OUTCOMES SAS1
MYELOMA PATIENTS EUROPE AISBL1
NATIONAL CANCER CENTER1
NOVO NORDISK1
ORCION BV1
ORSZAGOS GYOGYSZERESZETI ES ELELMEZESEGESZSEGUGYI INTEZET1
OSLO UNIVERSITETSSYKEHUS HF1
QUEEN'S UNIVERSITY AT KINGSTON1
REGION HOVEDSTADEN1
REGION STOCKHOLM1
SIMOMICS LIMITED1
ST GEORGE'S HOSPITAL MEDICAL SCHOOL1
STATENS LEGEMIDDELVERK1
STATNI USTAV PRO KONTROLU LECIV1
STICHTING ENTIS FOUNDATION1
STICHTING LAREB1
STICHTING RADBOUD UNIVERSITEIT1
STICHTING VUMC1
STIFTUNG FUR QUALITAT UND WIRTSCHAFTLICHKEIT IM GESUNDHEITSWESEN1
SWANSEA UNIVERSITY1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TEAM IT RESEARCH SL1
TERVEYDEN JA HYVINVOINNIN LAITOS1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE CRITICAL PATH INSTITUTE NON PROFIT CORPORATION1
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA1
THE MEDICINES AUTHORITY1
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST1
THE SYNERGIST1
THE UNIVERSITY OF EXETER1
THE UNIVERSITY OF MANCHESTER1
THE UNIVERSITY OF SYDNEY1
TTOPSTART BV1
UCB BIOPHARMA1
UNIVERSITA DEGLI STUDI DI FERRARA1

Constancy:

Total number of partners: 128
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 128
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-01-01Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) STARSparticipant1.986.00021